Pancreatic Neuroendocrine Tumor G1

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pancreatic Neuroendocrine Tumor G1 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT06016855

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroend…

This phase IV trial evaluates how well giving standard of care (SOC) peptide receptor radionuclide therapy (PRRT) after SOC surgical removal of as much tumor as…

United States6 participantsStarted 2024-05-31

Treatment: Tumor Debulking, Lutetium Lu 177 Dotatate

All recent trials (12 shown)

CompletedNot Applicable

NCT04727723

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in…

This is a multicentre long-term non-interventional study of adult subjects diagnosed with unresectable or metastatic, progressive, well differentiated (G1 and G…

Italy164 participantsStarted 2021-03-09

Treatment: Lutathera®

Active — Not RecruitingPhase 3

NCT03375320

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

This phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may h…

United States298 participantsStarted 2018-10-26

Treatment: Biospecimen Collection, Cabozantinib S-malate

Pancreatic Neuroendocrine Tumor G1

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroend…

All recent trials (12 shown)

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in…

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroend…

All recent trials (12 shown)

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in…

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed b…

Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic P…

Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib

Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Ca…

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocr…